Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
Adverum Biotechnologies (ADVM) - Cash on Hand
Cash on Hand as of December 2023 : $96.52 M
According to Adverum Biotechnologies
's latest financial reports the company has $96.52 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adverum Biotechnologies - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.18 B | -39.19% |
| 2021-12-31 | $0.30 B | -28.98% |
| 2020-12-31 | $0.42 B | 158.82% |
| 2019-12-31 | $0.16 B | -19.04% |
| 2018-12-31 | $0.20 B | 7.66% |
| 2017-12-31 | $0.19 B | -14.26% |
| 2016-12-31 | $0.22 B | -14.25% |
| 2015-12-31 | $0.25 B | 62.53% |
| 2014-12-31 | $0.15 B | 28163.12% |
| 2013-12-31 | $0.56 M | 57.98% |
| 2012-12-31 | $0.35 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 115.68% | 🇺🇸 USA |